- Home
- IRON vs CEPU Comparison
IRON vs CEPU Comparison
Compare IRON & CEPU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRON
- CEPU
- Stock Information
- Founded
- IRON 2017
- CEPU 1989
- Country
- IRON United States
- CEPU Argentina
- Employees
- IRON N/A
- CEPU N/A
- Industry
- IRON Biotechnology: Pharmaceutical Preparations
- CEPU Electric Utilities: Central
- Sector
- IRON Health Care
- CEPU Utilities
- Exchange
- IRON Nasdaq
- CEPU Nasdaq
- Market Cap
- IRON 2.0B
- CEPU 1.7B
- IPO Year
- IRON N/A
- CEPU 2018
- Fundamental
- Price
- IRON $60.35
- CEPU $11.02
- Analyst Decision
- IRON Strong Buy
- CEPU Hold
- Analyst Count
- IRON 11
- CEPU 1
- Target Price
- IRON $95.73
- CEPU $12.00
- AVG Volume (30 Days)
- IRON 325.5K
- CEPU 227.1K
- Earning Date
- IRON 08-07-2025
- CEPU 08-11-2025
- Dividend Yield
- IRON N/A
- CEPU 2.82%
- EPS Growth
- IRON N/A
- CEPU N/A
- EPS
- IRON N/A
- CEPU 0.12
- Revenue
- IRON N/A
- CEPU $628,806,380.00
- Revenue This Year
- IRON N/A
- CEPU $22.91
- Revenue Next Year
- IRON N/A
- CEPU N/A
- P/E Ratio
- IRON N/A
- CEPU $11.44
- Revenue Growth
- IRON N/A
- CEPU N/A
- 52 Week Low
- IRON $30.82
- CEPU $8.50
- 52 Week High
- IRON $68.73
- CEPU $16.60
- Technical
- Relative Strength Index (RSI)
- IRON 57.22
- CEPU 36.46
- Support Level
- IRON $57.54
- CEPU $10.77
- Resistance Level
- IRON $64.83
- CEPU $11.39
- Average True Range (ATR)
- IRON 2.14
- CEPU 0.57
- MACD
- IRON -0.19
- CEPU -0.18
- Stochastic Oscillator
- IRON 46.60
- CEPU 9.51
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
About CEPU Central Puerto S.A. (each represents ten)
Central Puerto SA is a power generation company. It is mainly engaged in electric power generation and commercialization. The company is also involved in the natural gas distribution public sector service in the Cuyo and Centro regions in Argentina. The Group has four reporting segments which includes electric power generation from conventional sources, electric power generation from renewable sources, natural gas transport and distribution, and forest activity.. The company derives maximum revenue from Electric Power Generation from conventional sources segment.